167.91
price up icon1.30%   2.15
pre-market  Pre-mercato:  167.91  
loading
Precedente Chiudi:
$165.76
Aprire:
$167.17
Volume 24 ore:
1.39M
Relative Volume:
0.58
Capitalizzazione di mercato:
$35.49B
Reddito:
$398.11M
Utile/perdita netta:
$-1.03B
Rapporto P/E:
-29.44
EPS:
-5.7032
Flusso di cassa netto:
$-868.57M
1 W Prestazione:
+2.42%
1M Prestazione:
+15.99%
6M Prestazione:
+131.12%
1 anno Prestazione:
+125.26%
Intervallo 1D:
Value
$163.42
$168.22
Intervallo di 1 settimana:
Value
$161.19
$168.22
Portata 52W:
Value
$60.40
$168.22

Insmed Inc Stock (INSM) Company Profile

Name
Nome
Insmed Inc
Name
Telefono
908-977-9900
Name
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
Dipendente
1,271
Name
Cinguettio
@insmed
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
INSM's Discussions on Twitter

Confronta INSM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
INSM
Insmed Inc
167.91 35.04B 398.11M -1.03B -868.57M -5.7032
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
419.10 106.87B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
491.22 63.14B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
576.77 61.27B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
849.46 51.94B 3.06B 1.28B 447.35M 19.67

Insmed Inc Stock (INSM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-20 Iniziato Wells Fargo Overweight
2025-08-20 Iniziato William Blair Outperform
2025-08-13 Downgrade Morgan Stanley Overweight → Equal-Weight
2025-05-13 Iniziato Jefferies Buy
2025-02-25 Iniziato RBC Capital Mkts Outperform
2024-04-23 Iniziato Truist Buy
2024-02-15 Iniziato Wolfe Research Outperform
2023-12-08 Iniziato Wells Fargo Overweight
2023-11-20 Ripresa JP Morgan Overweight
2023-07-26 Iniziato Guggenheim Buy
2022-12-09 Iniziato Mizuho Buy
2022-12-07 Iniziato Barclays Overweight
2022-11-18 Iniziato BofA Securities Buy
2022-04-27 Iniziato Goldman Buy
2021-12-06 Iniziato JP Morgan Overweight
2021-10-19 Ripresa Monness Crespi & Hardt Buy
2021-10-19 Ripresa Morgan Stanley Overweight
2021-10-08 Iniziato Cantor Fitzgerald Overweight
2021-04-26 Ripresa Credit Suisse Outperform
2020-12-17 Iniziato Berenberg Buy
2020-10-12 Ripresa Stifel Buy
2019-09-03 Iniziato Goldman Buy
2019-04-09 Reiterato H.C. Wainwright Buy
2019-02-15 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 Aggiornamento Goldman Neutral → Buy
2019-01-02 Iniziato Canaccord Genuity Buy
2018-08-06 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 Iniziato Goldman Neutral
2018-04-23 Aggiornamento Credit Suisse Neutral → Outperform
2018-03-21 Iniziato Morgan Stanley Overweight
2018-01-18 Iniziato Credit Suisse Neutral
2017-09-05 Reiterato Evercore ISI Outperform
2017-08-17 Iniziato Evercore ISI Outperform
2017-07-11 Iniziato Robert W. Baird Outperform
2016-03-15 Iniziato Stifel Buy
2015-11-09 Downgrade UBS Buy → Neutral
2015-10-06 Reiterato H.C. Wainwright Buy
2015-06-09 Iniziato Citigroup Neutral
2014-03-26 Reiterato HC Wainwright Buy
Mostra tutto

Insmed Inc Borsa (INSM) Ultime notizie

pulisher
Oct 20, 2025

Is Insmed Incorporated (IM8N) stock among top earnings playsTrade Performance Summary & Low Drawdown Investment Ideas - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Insmed Incorporated stock volume spike explainedJuly 2025 Closing Moves & Long-Term Capital Growth Strategies - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Why Insmed Incorporated (IM8N) stock is listed among top recommendationsQuarterly Risk Review & Accurate Entry and Exit Point Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

How to build a custom watchlist for Insmed IncorporatedMarket Performance Report & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Will Insmed Incorporated (IM8N) stock see valuation expansionMarket Performance Summary & Consistent Profit Trading Strategies - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Insmed Inc stock reaches 52-week high at 167.0 USD By Investing.com - Investing.com Canada

Oct 20, 2025
pulisher
Oct 20, 2025

Insmed Inc stock reaches 52-week high at 167.0 USD - Investing.com

Oct 20, 2025
pulisher
Oct 20, 2025

Insmed Incorporated (INSM): Analyst Consensus Signals Strong Growth Potential Amid Biotech Innovations - DirectorsTalk Interviews

Oct 20, 2025
pulisher
Oct 20, 2025

How to interpret RSI for Insmed Incorporated stock2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

What indicators show strength in Insmed IncorporatedJuly 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com

Oct 19, 2025
pulisher
Oct 19, 2025

What moving averages say about Insmed Incorporated2025 Investor Takeaways & Verified Trade Idea Suggestions - newser.com

Oct 19, 2025
pulisher
Oct 19, 2025

Volatility clustering patterns for Insmed IncorporatedInsider Selling & Fast Gain Swing Alerts - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Short Covering: Why Insmed Incorporated stock could benefit from AI revolutionPortfolio Gains Summary & Safe Capital Growth Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

How Insmed Incorporated stock reacts to Fed rate cutsPortfolio Update Summary & Reliable Intraday Trade Plans - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Is Insmed Incorporated trending in predictive chart modelsMarket Performance Summary & Real-Time Stock Entry Alerts - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Retail Surge: Can Insmed Incorporated stock hit analyst price targets2025 Major Catalysts & AI Driven Price Predictions - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Why Insmed Incorporated stock attracts global investorsWeekly Stock Summary & Fast Moving Stock Watchlists - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Why Insmed Incorporated stock could benefit from AI revolutionMarket Growth Summary & Safe Capital Allocation Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Should Insmed’s (INSM) EMA Nod for BRINSUPRI Prompt a Fresh Look at Its Growth Prospects? - Yahoo Finance

Oct 18, 2025
pulisher
Oct 17, 2025

EMA Backs Insmed’s Brinsupri And Sanofi’s Wayrilz, Rejects Rezurock - Citeline News & Insights

Oct 17, 2025
pulisher
Oct 17, 2025

Sanofi, Insmed among winners of CHMP recommendations (SNY) - Seeking Alpha

Oct 17, 2025
pulisher
Oct 17, 2025

Insmed Says Non-Cystic Fibrosis Bronchiectasis Treatment Recommended for EU Approval - MarketScreener

Oct 17, 2025
pulisher
Oct 17, 2025

Insmed (INSM) Receives Positive EMA Recommendation for BRINSUPRI - GuruFocus

Oct 17, 2025
pulisher
Oct 17, 2025

Insmed Incorporated CHMP Recommends EU Approval of Brinsupri (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis - MarketScreener

Oct 17, 2025
pulisher
Oct 17, 2025

CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis - PR Newswire

Oct 17, 2025
pulisher
Oct 16, 2025

What institutional flow reveals about Insmed IncorporatedPortfolio Risk Summary & Daily Entry Point Alerts - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025 - PR Newswire

Oct 16, 2025
pulisher
Oct 15, 2025

Is a relief rally coming for Insmed Incorporated holdersJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

What dividend safety score for Insmed Incorporated stockPortfolio Value Summary & High Conviction Investment Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Does Insmed Incorporated (INSM) Have a Promising Pipeline? - Yahoo Finance

Oct 15, 2025
pulisher
Oct 15, 2025

Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025 - MarketScreener

Oct 15, 2025
pulisher
Oct 15, 2025

Q3 2025 Results on Oct. 30 — Insmed Schedules Investor Call; Live Webcast & Replay - Stock Titan

Oct 15, 2025
pulisher
Oct 15, 2025

This Is What Whales Are Betting On Insmed - Sahm

Oct 15, 2025
pulisher
Oct 15, 2025

Biotech Fund Beating 92% of Peers Sees More M&A Deals to Come - Bloomberg.com

Oct 15, 2025
pulisher
Oct 14, 2025

UBS Maintains Insmed (INSM) Buy Recommendation - Nasdaq

Oct 14, 2025
pulisher
Oct 14, 2025

Can Insmed Incorporated hit a new high this monthMarket Performance Summary & Daily Entry Point Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Insmed, Inc. Hits New 52-Week High of $166.44, Up 173.69% - Markets Mojo

Oct 14, 2025
pulisher
Oct 14, 2025

UBS Raises Price Target for Insmed (INSM) Following Consistent " - GuruFocus

Oct 14, 2025
pulisher
Oct 14, 2025

Insmed stock price target raised to $194 from $140 at UBS on new indications - Investing.com Canada

Oct 14, 2025
pulisher
Oct 14, 2025

UBS Adjusts Insmed Price Target to $194 From $140, Maintains Buy Rating - MarketScreener

Oct 14, 2025
pulisher
Oct 14, 2025

Key metrics from Insmed Incorporated’s quarterly dataJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com

Oct 14, 2025

Insmed Inc Azioni (INSM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
biotechnology ONC
$318.59
price up icon 0.69%
$107.95
price up icon 2.67%
$30.54
price down icon 7.93%
$849.46
price up icon 0.69%
$86.17
price down icon 1.60%
Capitalizzazione:     |  Volume (24 ore):